Your browser doesn't support javascript.
loading
Letter to the Editor: Enhancing the rigor and impact of cholangiocarcinoma research: Addressing key concerns in the PTPN9-FGFR2 interaction study.
Zhu, Meng; Qu, Mengqi; Lv, Shengxia; Zhang, Jinfang; Zhang, Yongsheng; Pan, Fuzhen.
Affiliation
  • Zhu M; School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
  • Qu M; School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
  • Lv S; School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
  • Zhang J; Cancer Center, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
  • Zhang Y; School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
  • Pan F; Cancer Center, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
Hepatology ; 80(3): E44-E45, 2024 Sep 01.
Article in En | MEDLINE | ID: mdl-38913552
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma / Receptor, Fibroblast Growth Factor, Type 2 Limits: Humans Language: En Journal: Hepatology Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma / Receptor, Fibroblast Growth Factor, Type 2 Limits: Humans Language: En Journal: Hepatology Year: 2024 Document type: Article